| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/11/2010 | WO2010015585A1 6-benzyl-2,3,4,7-tetrahydro-indolo[2,3-c]quinoline compounds |
| 02/11/2010 | WO2010015583A1 Novel diphenyl 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors |
| 02/11/2010 | WO2010015567A2 Controlled release formulations using intelligent polymers |
| 02/11/2010 | WO2010015556A1 Film-forming liquid formulations for drug release to hair and scalp |
| 02/11/2010 | WO2010015529A1 New no releasing steroids derivatives |
| 02/11/2010 | WO2010015528A1 New no-releasing steroids for the treatment of retina and macula lutea diseases |
| 02/11/2010 | WO2010015523A1 Cyclohexyloxy-substituted heterocyclics, medicines containing these compounds and method for the production thereof |
| 02/11/2010 | WO2010015522A1 Cyclohexyloxy-substituted heterocyclics, medicines containing these compounds and method for the production thereof |
| 02/11/2010 | WO2010015520A1 Substituted naphthyridines and use thereof as medicines |
| 02/11/2010 | WO2010015518A2 4-dimethylamino-phenyl-substituted naphthyridines, and use thereof as medicaments |
| 02/11/2010 | WO2010015447A1 Angiotensin ii receptor antagonists |
| 02/11/2010 | WO2010015400A2 Injectable taxane pharmaceutical composition |
| 02/11/2010 | WO2010015387A1 Daa-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment |
| 02/11/2010 | WO2010015372A1 Pregnancy prevention using gestagens |
| 02/11/2010 | WO2010015340A1 Daa-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment |
| 02/11/2010 | WO2010015335A1 Long-term treatment of symptomatic heart failure |
| 02/11/2010 | WO2010015324A1 Quinuclidine carbonate derivatives and medicinal composition thereof |
| 02/11/2010 | WO2010015260A2 Administration by infusion for the treatment of ischemic effects |
| 02/11/2010 | WO2010015253A1 Pharmaceutical composition for nasal application |
| 02/11/2010 | WO2010015212A1 COMPOUND WITH AGITATION EFFECT ON PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR δ, AND PREPARATION METHOD AND USE THEREOF |
| 02/11/2010 | WO2010015205A1 The use of sophoricoside in preparing medicaments |
| 02/11/2010 | WO2010015148A1 Oligodeoxynucleotides with function of immunosuppression |
| 02/11/2010 | WO2010015144A1 The hydrosulfate of prasugrel, its pharmaceutical combination and uses thereof |
| 02/11/2010 | WO2010015040A1 Therapy and prevention of tdp-43 proteinopathy |
| 02/11/2010 | WO2010015037A1 Therapeutic methods and compositions |
| 02/11/2010 | WO2010015032A1 Methods of treating and preventing glucose toxicity |
| 02/11/2010 | WO2010015029A1 Compositions and methods for treating psychiatric disorders |
| 02/11/2010 | WO2009157858A8 Use of cyclolignans for the treatment of a hyperactive immune system |
| 02/11/2010 | WO2009155070A3 Compositions and methods for treatment of inflammation and hyperkeratotic lesions |
| 02/11/2010 | WO2009154754A3 Synthesis of deuterated morpholine derivatives |
| 02/11/2010 | WO2009152164A3 Smoking cessation kit and method |
| 02/11/2010 | WO2009141532A3 Derivatives of 1,5-diphenyl pyrrole-3-carboxamide, preparation thereof and use of same as cannabinoid cb1 receptor antagonists |
| 02/11/2010 | WO2009138386A3 Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use |
| 02/11/2010 | WO2009129300A3 Oral pharmaceutical compositions in a solid dispersion comprising preferably posaconazole and hpmcas |
| 02/11/2010 | WO2009123764A3 Compositions and use of epas1 inhibitors |
| 02/11/2010 | WO2009120741A3 Inhibition of trim62 activity reduces cancer cell proliferation |
| 02/11/2010 | WO2009093141A3 Novel inhibitors of mycobacterium complex cytochrome p450 cyp121 |
| 02/11/2010 | WO2009017719A8 Modulators of ccr9 receptor and methods of use thereof |
| 02/11/2010 | WO2009001219A9 Immunocytokines for cancer treatment in combination with chemotherapeutic agents |
| 02/11/2010 | WO2008142550A9 Spirocyclic quinazoline derivatives and their use as pde7 inhibitors |
| 02/11/2010 | WO2008047249A3 Alpha-galactosylceramide analogs, their methods of manufacture, intermediate compounds useful in these methods, and pharmaceutical compositions containing them |
| 02/11/2010 | WO2008010070A3 Novel oxazolidinone derivatives |
| 02/11/2010 | US20100037353 Method for improving activity of reactive oxygen species scavenging enzymes |
| 02/11/2010 | US20100037328 Cd20-negatively converted b cell malignant lymphocyte cell line and utilization of the same |
| 02/11/2010 | US20100036387 Viscoelastic Composition for Surgical Procedures |
| 02/11/2010 | US20100036107 Rna interference compositions and methods |
| 02/11/2010 | US20100035998 Combination s-nitrosothiol pharmaceutical products for restoring normal breathing rhythms |
| 02/11/2010 | US20100035996 Glucose metabolism stimulating agent |
| 02/11/2010 | US20100035995 Compositions comprising Cyclohexylamines and Aminoadamantanes |
| 02/11/2010 | US20100035994 Novel hydrate form of o-desmethyl venlafaxine succinate |
| 02/11/2010 | US20100035993 Methods and compositions comprising 2-[(3-chlorophenyl) amino] phenylacetic acid for hyperpermeability and neovascularization disorders of the retina |
| 02/11/2010 | US20100035992 Methods and Compositions for Treating Inflammation and Inflammation-Related Pathologies |
| 02/11/2010 | US20100035991 Amide base salts of saha and polymorphis thereof |
| 02/11/2010 | US20100035990 Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (ppar) |
| 02/11/2010 | US20100035989 Compositions and methods for the treatment of mucositis |
| 02/11/2010 | US20100035988 Methods for activating PPAR gamma-type receptors |
| 02/11/2010 | US20100035987 Pleuromutilin derivatives for the treatment of diseases mediated by microbes |
| 02/11/2010 | US20100035986 Methods for the treatment and prevention of age-related retinal dysfunction |
| 02/11/2010 | US20100035984 Use of an antibacterial compound which is derived from alliaceae, as a natural additive in animal feed |
| 02/11/2010 | US20100035983 Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof |
| 02/11/2010 | US20100035982 Oxaliplatin formulations |
| 02/11/2010 | US20100035981 Particulate aqueous system for the preparation of a formulation for the treatment of adipose diseases |
| 02/11/2010 | US20100035980 Antiparasitic agents |
| 02/11/2010 | US20100035979 Compositions and Methods of Sensitizing Methicillin Resistant Staphylococcus Aureus to Oxacillin |
| 02/11/2010 | US20100035978 Combination of cannabinoids for the treatment of peripheral neuropathic pain |
| 02/11/2010 | US20100035977 Two-component taxane containing pharmaceutical composition |
| 02/11/2010 | US20100035976 Method of treating a tumor or a viral disease by administering a 2' , 5' -oligoadenylate analog |
| 02/11/2010 | US20100035975 Methods of preventing and treating respiratory viral infection using immunomodulatory polynucleotide sequences |
| 02/11/2010 | US20100035974 Compositions comprising a sirna and lipidic 4,5-disubstituted 2-deoxystreptamine ring aminoglycoside derivatives and uses thereof |
| 02/11/2010 | US20100035972 Oligonucleotide and use thereof |
| 02/11/2010 | US20100035971 Methods and Means Related to Diseases |
| 02/11/2010 | US20100035970 Methylation Markers for Diagnosis and Treatment of Cancers |
| 02/11/2010 | US20100035969 connective tissue growth factor (CTGF) expression inhibition; treating glaucoma, macular degeneration, diabetic retinopathy, choroidal neovascularization, proliferative vitreoretinopathy and wound healing |
| 02/11/2010 | US20100035968 Mediated cellular delivery of lna oligonucleotides |
| 02/11/2010 | US20100035967 Modulation of toll-like receptor 9 expression by antisense oligonucleotides |
| 02/11/2010 | US20100035966 Methods and compositions for regulating cell cycle progression |
| 02/11/2010 | US20100035965 Sirna inhibition of p13k p85, pa110, and akt2 and methods of use |
| 02/11/2010 | US20100035964 Antisense modulation of connective tissue growth factor expression |
| 02/11/2010 | US20100035963 Oligoribonucleotides and Methods of use Thereof for Treatment of Cardiovascular Disease |
| 02/11/2010 | US20100035962 Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with cyclohexyl groups, method for producing the same, drugs containing said compounds and use thereof |
| 02/11/2010 | US20100035961 Novel 1,4-benzothiepine 1,1-dioxide derivatives substituted by benzyl radicals, method for their preparation, pharmaceuticals comprising these compounds, and the use thereof |
| 02/11/2010 | US20100035960 Biosynthetic pathway and genes required for tropodithietic acid biosynthesis in silicibacter tm1040 |
| 02/11/2010 | US20100035959 Novel sphingosine kinase type 1 inhibitors, compositions and processes for using same |
| 02/11/2010 | US20100035958 Novel Compounds And Compositions Thereof |
| 02/11/2010 | US20100035957 Methods for the Use of Inhibitors of Cytosolic Phospholipase A2 |
| 02/11/2010 | US20100035956 Compounds Having CRTH2 Antagonist Activity |
| 02/11/2010 | US20100035955 Stabilised Composition Comprising ACE Inhibitors |
| 02/11/2010 | US20100035954 Acid addition salts of muscarinic receptor antagonists |
| 02/11/2010 | US20100035953 Pyrazole Phenyl Derivatives |
| 02/11/2010 | US20100035952 Radiosensitizer Formulations and Methods for Use |
| 02/11/2010 | US20100035951 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
| 02/11/2010 | US20100035949 Microemulsion dosage forms of valsartan and methods of making the same |
| 02/11/2010 | US20100035948 Furanone compounds and lactam analogues thereof |
| 02/11/2010 | US20100035947 Method for manufacturing neuraminic acid derivatives |
| 02/11/2010 | US20100035946 Indoline anti-cancer agents |
| 02/11/2010 | US20100035945 Small molecule inhibitors of bacterial dam dna methyltransferases |
| 02/11/2010 | US20100035944 Compounds and methods for modulating g protein-coupled receptors |
| 02/11/2010 | US20100035943 Oxa-and thiadiazoles and their use as metalloproteinase inhibitors |
| 02/11/2010 | US20100035942 1-orthofluorophenyl substituted 1,2,5-thiazolidinedione derivatives as ptp-as inhibitors |
| 02/11/2010 | US20100035941 Methods for increasing blood flow and/or promoting tissue regeneration |